MAKEDONIA PALACE HOTEL, THESSALONIKI, 5-8/10/2017

ΙΑSIS PHARMA participated dynamically in the 37th Panhellenic Gastroenterology Conference, which took place at Makedonia Palace Hotel, in Thessaloniki, Macedonia, November 24-27th 2016 and was organized by the Hellenic Society of Gastroenterology (E.G.E). The Panhellenic Gastroenterology Conference constitutes the top scientific event of E.G.E, aiming to update and educate every expert focusing on in gastroenterology and hepatology.

IASIS PHARMA demonstrated its active participation in the conference by presenting mastihatherapy® caps, the unique traditional herbal medicinal product which contains 350mg of pure Chios Mastic indicated for functional dyspepsia. Medical experts showed a strong interest about this herbal medicinal product that is known to humanity for over 2.500 years, having several historical reports, but also many scientific studies published in the recent times.

IASIS PHARMA is the only pharmaceutical company that is supplied with pure Chios Mastic directly from Chios Mastic Growers Association (EMX), ensuring the quality and authenticity of mastihatherapy® caps. The product is distributed only through pharmacies, in 30 caps or 90 caps packages, by pharma Q, an IASIS PHARMA company.

During the event, IASIS PHARMA had a poster presentation, under the title ” Development and application of HPLC-DAD and HPTLC methods for quality control of Chios Mastic and Products”, written by V. Pachi, E. Kallergis, A. Angelis, V. Brieudes, S. Mitakou, M. Halabalaki, L.A. Skaltsounis. The presentation attracted high interest among the attending specialists, by describing the method of detection for the unique ingredients of original Chios Mastic: masticadienonic acid and iso-masticadienonic acid, the substances that are responsible for the anti-inflammatory properties of the original Chios Mastic.
The above methodology has been developed exclusively by IASIS PHARMA, in cooperation with the University of Athens, and certifies the originality of pure Chios Mastic contained in the mastihatherapy® caps.

37-gstr-2    37-gstr-1